These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 11809)

  • 1. The action of psychotropic drugs on DOPA induced behavioural responses in mice.
    Berendsen H; Leonard BE; Rigter H
    Arzneimittelforschung; 1976; 26(9):1686-9. PubMed ID: 11809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the participation of the dopaminergic system in the central effects of chronically administered antidepressant drugs.
    Kozyrska C; Zebrowska-Lupina I
    Pol J Pharmacol Pharm; 1983; 35(2):115-26. PubMed ID: 6684769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings: The effect of psychotropic drugs on the dopa potentiation test in mice.
    Berendsen H; Leonard BE; Rigter H
    Br J Pharmacol; 1974 Nov; 52(3):432P-433P. PubMed ID: 4458854
    [No Abstract]   [Full Text] [Related]  

  • 5. [Psychopharmacologic spectrum of melanostatin].
    Val'dman AV; Kozlovskaia MM; Klusha VE; Svirskis ShV
    Biull Eksp Biol Med; 1980 Jun; 89(6):693-6. PubMed ID: 6104996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic MIF analogues. Part II: Dopa potentiation and fluphenazine antagonism.
    Voith K
    Arzneimittelforschung; 1977; 27(12):2290-3. PubMed ID: 23795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological evaluation of 2-(4-methylaminobutoxy)diphenylmethane hydrochloride (MCI-2016), a new psychotropic drug with antidepressant activity.
    Tobe A; Yoshida Y; Ikoma H; Tonomura S; Kikumoto R
    Arzneimittelforschung; 1981; 31(8):1278-85. PubMed ID: 7197535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the involvement of the monoaminergic system in the antidepressant-like action of two 4-amine derivatives of 10,11-dihydro-5H-dibenzo [a,d] cycloheptane in mice evaluated in the tail suspension test.
    Duarte FS; Lach G; Martins PR; Romeiro GA; de Lima TC
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):368-74. PubMed ID: 17920179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of mianserin on functions of ascending and descending monoaminergic systems, using experimental models (author's transl)].
    Sakai Y; Deguchi T
    Nihon Yakurigaku Zasshi; 1980 Apr; 76(3):213-25. PubMed ID: 6967847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological properties of 2,3,3a,4,5,6-hexahydro-8-methyl-1H-pyrazino [3,2,1-j,k]carbazol hydrochloride (pirlindole), a new antidepressant.
    Mashkovsky MD; Andrejeva NI
    Arzneimittelforschung; 1981; 31(1):75-9. PubMed ID: 7194096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential antidepressant activity and enhancement of serotonin uptake of a new dibenzothiadiazepine derivative.
    Borsini F; Volterra G; Lecci A; Evangelista S; Mancinelli A; Cutrufo C; Parlani M; Mennini T; Barone D; Meli A
    Arzneimittelforschung; 1991 Jun; 41(6):573-80. PubMed ID: 1718290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of monoamine neural systems in L-dihydroxyphenylalanine-stimulated activity.
    Hollister AS; Breese GR; Mueller RA
    J Pharmacol Exp Ther; 1979 Jan; 208(1):37-43. PubMed ID: 759613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple rodent assay for the in vivo identification of agents with potential to reduce levodopa-induced dyskinesia in Parkinson's disease.
    Johnston TH; Lee J; Gomez-Ramirez J; Fox SH; Brotchie JM
    Exp Neurol; 2005 Feb; 191(2):243-50. PubMed ID: 15649479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sedative action of low doses of dopaminergic agents.
    Maj J; Przewlocka B; Kukulka L
    Pol J Pharmacol Pharm; 1977; 29(1):11-21. PubMed ID: 857245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant profile of 9-methyl-2[-3-(4-phenyl-1-piperazinylpropyl)]-1,2,3,4-tetrahydro-beta- carbolin-1-one (B-193).
    Wiczyńska B; Antkiewicz-Michaluk L; Pilc A; Chojnacka-Wójcik E; Przegaliński E
    Pol J Pharmacol Pharm; 1989; 41(4):331-44. PubMed ID: 2636891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
    Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
    Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The monoamine reuptake inhibitor BTS 74 398 fails to evoke established dyskinesia but does not synergise with levodopa in MPTP-treated primates.
    Hansard MJ; Smith LA; Jackson MJ; Cheetham SC; Jenner P
    Mov Disord; 2004 Jan; 19(1):15-21. PubMed ID: 14743355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional alteration by NMDA antagonist: effects of L-Dopa, neuroleptics drug and postnatal administration.
    Fredriksson A; Archer T
    Amino Acids; 2002; 23(1-3):111-32. PubMed ID: 12373526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of repeated administration of imipramine, citalopram and mianserin on responsiveness of central serotonergic, alpha 2-adrenergic and cholinergic system in mice.
    Maj J; Rogóz Z; Skuza G; Sowińska H
    Pol J Pharmacol Pharm; 1989; 41(4):313-9. PubMed ID: 2561380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of antidepressants with antiparkinsonian agents in rats.
    Zebrowska-Lupina I; Porowska A; Pietrasiewicz T
    Pol J Pharmacol Pharm; 1985; 37(6):865-74. PubMed ID: 3832020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.